These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14645137)

  • 21. Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats.
    Gendron G; Simard B; Gobeil F; Sirois P; D'Orléans-Juste P; Regoli D
    Can J Physiol Pharmacol; 2004 Jan; 82(1):16-21. PubMed ID: 15052301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position 9.
    Merlino F; Brancaccio D; Yousif AM; Piras L; Campiglia P; Gomez-Monterrey I; Santicioli P; Meini S; Maggi CA; Novellino E; Carotenuto A; Grieco P
    ChemMedChem; 2016 Aug; 11(16):1856-64. PubMed ID: 27061352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle.
    Behm DJ; Ao Z; Camarda V; Aiyar NV; Johns DG; Douglas SA
    Eur J Pharmacol; 2005 Jun; 516(3):276-81. PubMed ID: 15975570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction between human urotensin II and vasodilator agents in human internal mammary artery with possible clinical implications.
    Bai XY; Liu XC; Yang Q; Tang XD; He GW
    Ann Thorac Surg; 2011 Aug; 92(2):610-6. PubMed ID: 21704284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey.
    Douglas SA; Sulpizio AC; Piercy V; Sarau HM; Ames RS; Aiyar NV; Ohlstein EH; Willette RN
    Br J Pharmacol; 2000 Dec; 131(7):1262-74. PubMed ID: 11090097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstriction.
    Wang YX; Ding YJ; Zhu YZ; Shi Y; Yao T; Zhu YC
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H348-59. PubMed ID: 16951045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines.
    Douglas SA; Naselsky D; Ao Z; Disa J; Herold CL; Lynch F; Aiyar NV
    Br J Pharmacol; 2004 Jul; 142(6):921-32. PubMed ID: 15210573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular reactivity of isolated thoracic aorta of the C57BL/6J mouse.
    Russell A; Watts S
    J Pharmacol Exp Ther; 2000 Aug; 294(2):598-604. PubMed ID: 10900237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A quantitative study to assess synergistic interactions between urotensin II and angiotensin II.
    Lamarre NS; Tallarida RJ
    Eur J Pharmacol; 2008 May; 586(1-3):350-1. PubMed ID: 18371948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
    Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta.
    Webb ML; Dickinson KE; Delaney CL; Liu EC; Serafino R; Cohen RB; Monshizadegan H; Moreland S
    Biochem Biophys Res Commun; 1992 Jun; 185(3):887-92. PubMed ID: 1320879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human urotensin II increases coronary perfusion pressure in the isolated rat heart: potentiation by nitric oxide synthase and cyclooxygenase inhibition.
    Gray GA; Jones MR; Sharif I
    Life Sci; 2001 Jun; 69(2):175-80. PubMed ID: 11441907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of urotensin I induced vasodilatory action in rat thoracic aorta to Ca2+ regulation.
    Itoh H; Lederis K
    Can J Physiol Pharmacol; 1987 Mar; 65(3):298-302. PubMed ID: 3034389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, conformational analysis, and biological studies of urotensin-II lactam analogues.
    Grieco P; Carotenuto A; Patacchini R; Maggi CA; Novellino E; Rovero P
    Bioorg Med Chem; 2002 Dec; 10(12):3731-9. PubMed ID: 12413830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development of therapeutic agents related to urotensin II].
    Mori M
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():741-4. PubMed ID: 15506486
    [No Abstract]   [Full Text] [Related]  

  • 36. Urotensin-II receptor antagonism does not improve renal haemodynamics or function in rats with endotoxin-induced acute kidney injury.
    Nitescu N; Grimberg E; Guron G
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1170-5. PubMed ID: 20880186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urotensin II receptor (UTR) exists in hyaline chondrocytes: a study of peripheral distribution of UTR in the African clawed frog, Xenopus laevis.
    Konno N; Fujii Y; Imae H; Kaiya H; Mukuda T; Miyazato M; Matsuda K; Uchiyama M
    Gen Comp Endocrinol; 2013 May; 185():44-56. PubMed ID: 23399967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of heterologous receptor desensitization induced by angiotensin II type 1 receptor activation in isolated normal rat thoracic aorta.
    Pérez T; López RM; López P; Castillo C; Castillo EF
    Vascul Pharmacol; 2011; 54(1-2):29-35. PubMed ID: 21122823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of binding sites for human urotensin-II in Sprague-Dawley rat renal medulla using quantitative receptor autoradiography.
    Disa J; Floyd LE; Edwards RM; Douglas SA; Aiyar NV
    Peptides; 2006 Jun; 27(6):1532-7. PubMed ID: 16290260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by urotensin I, a selective mesenteric vasodilator peptide.
    Bolt GR; Itoh H; Lederis K; MacCannell KL
    J Pharmacol Exp Ther; 1987 Jul; 242(1):284-91. PubMed ID: 3039111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.